← The Wire
NKTXNasdaq
Nkarta, Inc.
Pharmaceutical Preparations · DE · CIK 1787400
Nkarta, Inc. develops allogeneic, off-the-shelf engineered natural killer cell therapies for patients
$205M
Market cap
$2.85
Last close
+0.7%
1D
+2.1%
5D
577K
Volume
Price · last 39 sessions-5.6%
May 4L $2.40 · H $3.32Jun 29
126
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 11, 2026SC 13D/ASC 13D/AMay 19, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 2026424B5424B5Apr 3, 20268-KCompany UpdateMar 26, 202610-K10-KMar 25, 20268-KResults of OperationsMar 25, 202610-Q10-QNov 10, 20258-KResults of OperationsNov 10, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KExecutive Change · Shareholder VoteJun 6, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEFA14ADEFA14AApr 21, 2025DEF 14ADEF 14AApr 21, 202510-K10-KMar 26, 20258-KExecutive Change · Results of OperationsMar 26, 2025SC 13GSC 13GDec 13, 2024SC 13GSC 13GNov 8, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GOct 24, 20248-K/AResults of OperationsAug 16, 202410-Q10-QAug 13, 20248-KMaterial AgreementAug 13, 20248-KExecutive Change · Reg FD DisclosureJul 16, 20248-KReg FD Disclosure · Company UpdateJun 27, 20248-KSecurity-Holder Rights · Bylaw AmendmentJun 13, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 20248-KCompany UpdateMar 28, 2024424B5424B5Mar 26, 20248-KReg FD Disclosure · Company UpdateMar 25, 202410-K10-KMar 21, 20248-KResults of OperationsMar 21, 2024SC 13GSC 13GJan 18, 20248-KReg FD DisclosureJan 8, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 2023SC 13GNKARTA, INC.Nov 3, 2023SC 13GSC 13GOct 27, 2023SC 13GSC 13GOct 26, 20238-KResults of Operations · Exit / Disposal CostsOct 17, 20238-KReg FD DisclosureOct 16, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KExecutive Change · Reg FD DisclosureJul 5, 20238-KReg FD Disclosure · Company UpdateJun 27, 20238-KReg FD DisclosureJun 26, 20238-KBylaw Amendment · Shareholder VoteJun 9, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEFA14AFORM DEFA14AApr 24, 2023DEF 14ADEF 14AApr 24, 20238-KExecutive Change · Reg FD DisclosureMar 30, 202310-K10-KMar 16, 20238-KResults of OperationsMar 16, 2023SC 13GSC 13GFeb 10, 2023SC 13GSC 13GFeb 9, 2023SC 13GSC 13GFeb 3, 20238-KReg FD DisclosureJan 9, 20238-KReg FD Disclosure · Company UpdateDec 5, 20228-KReg FD DisclosureDec 2, 202210-Q10-QNov 9, 20228-KResults of OperationsNov 9, 202210-Q10-QAug 11, 20228-KResults of OperationsAug 11, 20228-KShareholder VoteJun 10, 20228-KExecutive Change · Reg FD DisclosureMay 16, 202210-Q10-QMay 12, 20228-KResults of OperationsMay 12, 20228-KCompany UpdateApr 28, 2022424B5424B5Apr 26, 2022424B5424B5Apr 25, 2022
Insider Activity
In the 90 days to Jan 15, 2026: 2 sold $66K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 15, 2026 | Hastings Paul JChief Executive Officer | Sell | 26,046 | $2.07 | $54K |
| Jan 15, 2026 | Mahmood NadirPresident | Sell | 5,649 | $2.07 | $12K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance